WONTECH, a laser and energy-based medical device corporations, said on the 5th that it has completed the domestic medical device approval process for its laser-electrical stimulation fusion pain treatment solution "ELLESE" and will make a full-scale entry into the pain treatment market.
ELLESE is a product that WONTECH first unveiled at CES 2026 in the United States last month. By inserting a fiber-optic laser needle directly into the pain site to deliver energy, it overcame the limitations of conventional laser treatments that irradiate the skin surface.
The company said, "The existing method had the problem of energy scattering and weakening, but ELLESE can precisely deliver strong energy to the target point even at low output, enabling safe and effective treatment."
Low-level laser and electrical stimulation can be used alone or in combination. Depending on the treatment situation, the laser intensity and conditions can be finely adjusted to implement various pain treatment protocols with a single device, the company said. Its efficacy and safety were proven in clinical trials, and research results on its effect in treating chronic low back pain were published in the international journal PLOS ONE (Impact Factor 3.7), gaining international recognition.
Starting with this domestic approval, the company plans to expand into the pain treatment field and foster musculoskeletal pain treatment as a next-generation key growth driver. WONTECH has grown mainly in the aesthetic market by launching Oligio, a noninvasive monopolar radio frequency (RF) skin-lifting medical device, and Lavieen, a laser device used for pigmentation and skin improvement treatments.
A WONTECH official said, "ELLESE is a strategic product that extends proven technological capabilities from the aesthetic and dermatology laser market into the pain treatment field," adding, "With the world's first hybrid technology that fuses laser and electrical stimulation, it has overcome the limitations of existing treatments and secured differentiated competitiveness." The official said, "We will set a new standard for invasive laser pain treatment and gradually expand into global markets, including the United Arab Emirates, Singapore, the United States, Thailand and Japan."
Meanwhile, according to market research firm Grand View Research, the global pain treatment device market is projected to grow from about 11 trillion won in 2024 to about 26 trillion won in 2035. The compound annual growth rate is 9.6%.